- Reata Pharmaceuticals ( RETA ) +175% Pharmaceuticals up 192% on Friedreich's ataxia drug omaveloxolone approval.
- OncoSec Medical ( ONCS ) +94% .
- Lionheart III ( LION ) +53% .
- Sarepta Therapeutics ( SRPT ) +15% gains 18% as Morgan Stanley upgrades citing FDA approval for gene therapy.
- B&G Foods ( BGS ) +13% Q4 Earnings call release
- Nerdy ( NRDY ) +13% Q4 earnings call release
- Amplify Energy ( AMPY ) +11% Reaches $96.5 Million Settlement with the Shipping Companies Related to the Containerships’ Anchor Strikes of Amplify’s Pipeline.
- Larimar Therapeutics ( LRMR ) +11% .
- Payoneer Global ( PAYO ) +10% Q4 earnings call release
- Enel Chile ( ENIC ) +10% .
- G Medical Innovations Holdings ( GMVD ) +9% .
- JinkoSolar Holding ( JKS ) +9% .
- Bilibili ( BILI ) +8% .
- Cidara Therapeutics ( CDTX ) +8% Announces Promising Interim Phase 2a Data Assessing the Safety and Efficacy of a Single Dose of CD388 in an Influenza Challenge Model.
- ImmunoGen ( IMGN ) +8% pact with ImmunoGen to expand gene editing reach.
- Zhihu ( ZH ) +8% .
- GDS Holdings ( GDS ) +7% .
- NetEase ( NTES ) +7% .
- Dada Nexus ( DADA ) +7% to Announce Unaudited Fourth Quarter and Fiscal Year 2022 Financial Results on March 8, 2023.
- KE Holdings ( BEKE ) +7% .
- Yatsen Holding ( YSG ) +6% to Announce Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023.
- DouYu International Holdings ( DOYU ) +6% .
- RLX Technology ( RLX ) +6% to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 10, 2023.
- Baidu ( BIDU ) +6% .
- Tuniu ( TOUR ) +6% .
For further details see:
BIDU, JKS and BILI are among pre market gainers